刚毛柽柳ThPCS 1基因克隆与镉胁迫应答分析

[目的]探究刚毛柽柳(Tamarix hispida)植物络合素合酶(phytochelatin synthase,PCS)基因ThPCS1的镉胁迫应答功能.[方法]通过逆转录聚合酶链式反应(RT-PCR)对刚毛柽柳ThPCS1基因进行克隆;通过BioEdit、MEGA 5.0等软件对ThPCS1蛋白进行生物信息学分析...     

GmGSL7c在大豆抗SMV过程中的作用

为了阐明大豆Glycine max(L.)Merr.胼脈质合酶在大豆抵御大豆花叶病毒(Soybean mosaic oirus,SMV)侵染过程中的关键作用,采用生物信息学方法在大豆中鉴定出24个胼胝质合酶,并挑选出受一氧化氮(NO)影响且参与SMV抗性调控的大豆胼胝质合酶Glyma.08G308200(GmGSL7c...     

Glycogen synthase kinase 3: A key regulator of cellular fate

The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified as a key regulator of insulin-dependent glycogen synthesis. GSK-3 was subsequently shown to function in a wide range of cellular processes including differentiation, growth, motility and apoptosis. Aberrant regulation of GSK-3 has been implicated in a range of human pathologies including Alzheimer’s disease, non-insulin-dependent diabetes mellitus (NIDDM) and cancer. As a consequence, the regulation of GSK-3 and the therapeutic potential of GSK-3 inhibitors have become key areas of investigation. This review will focus on the mechanisms of GSK-3 regulation, with emphasis on modulation by upstream signals, control of substrate specificity and GSK-3 localisation. The details of these mechanisms will be discussed in the context of specific signalling pathways. Received 30 January 2007; received after revision 5 March 2007; accepted 16 April 2007     

RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies

Tauopathies are a group of neurodegenerative diseases characterised by intracellular deposits of the microtubule-associated protein tau. The most typical example of a tauopathy is Alzheimer’s disease. The importance of tau in neuronal dysfunction and degeneration has been demonstrated by the discovery of dominant mutations in the MAPT gene, encoding tau, in some rare dementias. Recent developments have shed light on the significance of tau phosphorylation and aggregation in pathogenesis. Furthermore, emerging evidence reveals the central role played by tau pre-mRNA processing in tauopathies. The present review focuses on the current understanding of tau-dependent pathogenic mechanisms and how realistic therapies for tauopathies can be developed. Received 3 December 2006; received after revision 23 February 2007; accepted 20 March 2007     

海藻糖对植物糖代谢的调控及糖感受的介导

对比了蔗糖与海藻糖的代谢,概述了6-磷酸海藻糖合成酶（TPS）、6-磷酸海藻糖磷酸酯酶（TPP）、海藻糖酶的分子特性。例举海藻糖在植物糖代谢的调控及糖感受的机制方面的研究进展。     

纤维微菌海藻糖合成酶基因克隆表达及酶学特性鉴定

【目的】开发适用于海藻糖生产的新型海藻糖合成酶。【方法】通过反向PCR技术,从一株纤维微菌的基因组DNA中获知海藻糖合成酶基因完整ORF序列,进而克隆得到纤维微菌海藻糖合成酶基因(CCTreS),将其与表达载体pSE380构建重组质粒后转入大肠杆菌BL-21(DE3)中诱导表达,通过镍柱亲和层析纯化得到纯酶并进行酶学性质测定。【结果】从纤维微菌中克隆并在大肠杆菌中成功表达海藻糖合成酶基因(CCTreS)。经纯化获得的重组酶(CCTreS)在以麦芽糖为底物生成海藻糖时,最适反应pH值为7.0,最适反应温度为45℃,40℃保温1h仍具有80%以上的相对酶活力,在pH值5.5~8.5保存24h,相对酶活力仍保留80%以上。Cu~(2+)对其有明显抑制作用。【结论】该重组酶具有很好的热稳定性和pH稳定性,具有一定的研究价值和潜在的工业应用价值。     

熊果酸抑制脂肪酸合酶及诱导HepG2细胞凋亡机制研究

采用MTT法检测发现熊果酸引起肝癌细胞HepG2活性下降的半抑制浓度IC50为68.23μmol.L-1,通过Hoechst 33258染色法检测得出熊果酸诱导HepG2细胞的凋亡,其作用强度呈药物浓度依赖性.在HepG2细胞培养过程中,加入熊果酸后细胞内脂肪酸合成酶（FAS）的表达量及活性降低.在培养基中添加棕榈酸钠可以在一定程度上补救熊果酸引起的HepG2细胞凋亡.推论熊果酸下调FAS的表达影响了脂肪酸合成,肿瘤细胞缺乏正常代谢所需要的能量及原料,导致肿瘤细胞凋亡.     

补充白藜芦醇对大强度运动大鼠心肌损伤的保护作用

目的:探讨RES对大强度运动心肌过氧化损伤的保护作用.方法:在活动跑台上建立大强度运动模型,测试心肌各项过氧化损伤指标.结果:大强度运动可造成大鼠心肌MDA,TNOS,iNOS,NO显著升高,TSOD,CuZn-SOD,GSH-Px,cNOS,Na+,K+-ATPase,Ca2+-ATPase显著下降.补充RES可使大鼠运动后心肌MDA,TNOS,iNOS,NO下降,TSOD,CuZn-SOD,Mn-SOD,GSH-Px,cNOS,Na+,K+-ATPase,Ca2+-ATPase升高.结论:RES可增强心肌的抗氧化能力,保持心肌酶活性.提示RES对大强度运动后心肌过氧化损伤具有保护作用.     

大别山区葛根黄酮对四氧嘧啶糖尿病模型小鼠糖脂代谢的影响

为研究葛根黄酮(RPF)对糖尿病模型小鼠糖脂代谢的影响及其可能的作用机制,采用四氧嘧啶(ALX,220mg/kg)腹腔注射建立糖尿病小鼠模型。RPF连续灌胃15d后摘眼球取血,分离血清,测定血糖、血清甘油三酯(TG)、总胆固醇(TC)、一氧化氮(NO)和一氧化氮合酶(NOS)水平;取肝、肾脏制成10%匀浆测定其NO和NOS水平;观察胰腺病理学形态变化。结果显示RPF能降低ALX诱导的糖尿病模型小鼠血糖、血清和肝脏中NO和NOS。其降糖机制可能与降低血清、肝脏的NO和NOS水平有关。     

三唑并嘧啶-2-磺酰胺类除草剂的研究进展

结合本课题组的工作，从合成、构效关系、代谢三个方面对1，2，4-三唑并[1，5-a]嘧啶-2-磺酰胺类除草剂的研究进展情况进行了简要概述。